TSS:Rfhg 93384.1

Basic information about the TSS

---

TSS ID: rfhg_93384.1 Species: human Chr: chr7		Start: 35832863 End: 35832884 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000425198.1:-65 HQ258243:-65 KJ901328:-65 GeneID: 989 HGNC/MGI_ID: HGNC:1717 UniProt_ID: Nearer transcript ids and distances: ENST00000399035.7:-194

Gene_name: SEPTIN7 Gene_symbol: SEPTIN7 Gene_synonyms: CDC3 SEPT7A Gene_source: HGNC:1717

TATA-Box annotation

---

Distance to TSS:	31654
Nearest PromoterID:	NM_001363715
Entrez ID:	989
Nearest Unigene:	Hs.191346
Nearest Refseq:	NM_001788
Nearest Ensembl:	ENSG00000122545
Gene Name:	SEPTIN7
Gene Alias:	CDC10|CDC3|NBLA02942|SEPT7|SEPT7A
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.409091
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SEPTIN7 p2@SEPTIN7 p3@SEPTIN7 p4@SEPTIN7 p5@SEPTIN7
Sample		p1@SEPTIN7	p2@SEPTIN7	p3@SEPTIN7	p4@SEPTIN7	p5@SEPTIN7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	64.67	2.14	0.78	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	55.44	1.82	0.40	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	67.90	1.74	0.77	0.19	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	58.01	2.29	0.83	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	59.17	1.80	0.45	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	55.62	3.10	0.78	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.48	1.96	1.53	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	76.78	3.15	1.21	0.48	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	55.99	1.71	1.07	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	59.70	1.16	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.06	1.21	1.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	58.54	1.22	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.07	0.32	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	61.04	0.45	0.00	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	45.45	0.88	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	41.75	0.50	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	46.08	0.44	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.54	0.00	2.11	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	0.00	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.58	0.30	0.90	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.58	0.27	0.67	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	57.31	0.35	0.69	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	52.74	0.13	0.13	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	43.44	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.79	0.26	0.77	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.88	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	52.20	0.55	1.10	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	59.41	0.24	0.24	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.67	0.32	0.32	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	54.83	0.36	0.36	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.98	0.42	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.90	0.20	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.93	0.84	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	69.27	0.66	0.82	0.33	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	49.55	0.37	0.19	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.32	0.57	0.77	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	44.15	1.23	0.00	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	45.13	0.81	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.10	0.54	0.81	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.73	0.24	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.76	0.24	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.22	0.44	1.02	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	43.65	0.63	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	46.33	0.70	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.80	1.00	0.20	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	54.67	0.93	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.70	0.00	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.97	0.30	0.30	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.16	1.20	0.72	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	46.91	0.61	0.81	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	62.72	0.61	0.61	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	60.49	0.22	1.11	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1637.09	0.00	27.98	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	38.32	1.06	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	49.71	0.33	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	366.62	3.36	1.68	0.84	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	107.92	1.84	0.92	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.16	0.65	0.97	0.00	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.72	0.32	0.96	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	114.73	2.51	1.26	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	40.19	0.00	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.67	2.24	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	175.95	0.80	2.39	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	94.46	0.68	1.02	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	45.81	0.00	1.30	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.44	1.06	1.06	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2101.31	16.16	0.00	32.33	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1840.11	23.69	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	48.75	0.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	52.56	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	56.29	0.47	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	70.21	1.99	0.33	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	56.61	0.62	0.62	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	40.66	0.31	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	158.07	5.39	3.96	1.58	0.48
Adipocyte - breast, donor2	11327-117E4	75.40	2.73	3.05	1.44	0.64
Adipocyte - omental, donor1	11473-119C6	165.40	13.49	7.25	5.22	0.38
Adipocyte - omental, donor2	11474-119C7	70.26	8.22	4.48	2.99	0.75
Adipocyte - omental, donor3	11475-119C8	72.01	6.36	2.68	3.01	0.67
Adipocyte - perirenal, donor1	11476-119C9	59.97	5.74	7.02	1.91	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	81.74	2.26	1.81	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	31.45	1.04	1.39	0.70	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	122.82	1.96	1.96	0.78	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	65.89	3.09	2.06	1.54	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	77.78	1.95	3.35	1.39	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	59.37	2.35	2.35	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	106.65	2.98	2.57	1.45	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	74.23	1.94	1.61	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	46.92	2.13	1.07	1.07	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	42.85	1.11	2.78	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	34.52	2.08	2.08	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	56.26	1.26	1.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	52.69	3.60	2.62	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	47.50	2.74	1.52	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	20.99	1.10	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.15	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.13	1.62	0.90	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	0.41	0.62	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	150.24	1.26	2.29	1.49	0.11
Anulus Pulposus Cell, donor2	11463-119B5	47.76	0.49	1.96	1.96	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	55.71	3.15	2.25	2.25	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	61.65	2.60	3.04	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	51.37	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	75.33	1.49	2.09	1.79	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	65.76	3.79	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	47.53	3.30	1.32	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	48.73	4.87	1.95	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	69.42	3.88	2.43	1.94	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	49.29	1.19	2.38	0.59	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	70.43	3.39	2.64	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	2.90	2.90	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	37.61	0.00	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	104.94	3.62	3.13	1.32	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	47.77	1.36	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	78.11	1.51	1.51	0.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	56.79	2.68	4.29	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.80	2.65	3.40	1.32	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	65.22	4.01	4.01	0.53	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	48.77	1.95	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	71.65	3.81	3.81	1.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	51.63	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.81	2.74	2.40	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	68.93	3.40	3.88	1.46	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	85.00	3.04	2.28	1.90	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	53.30	2.42	2.42	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	57.00	3.99	4.56	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	58.79	2.35	2.14	1.71	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	50.84	2.58	2.58	1.03	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	55.37	3.28	1.88	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	55.31	2.89	2.57	0.96	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	52.80	0.00	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	2.92	1.17	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	66.84	3.01	2.41	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	36.83	3.56	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	65.10	4.07	3.05	2.03	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	69.78	3.31	1.78	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	37.49	1.91	2.54	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	56.53	1.73	1.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	70.49	3.81	1.69	1.48	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	42.34	1.74	1.45	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	2.83	4.72	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	59.50	3.22	2.54	1.19	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	63.47	2.36	1.72	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	46.93	1.80	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	48.11	5.10	2.92	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	69.42	1.84	2.07	1.61	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	76.27	4.32	3.05	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	68.13	4.13	2.48	1.24	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	51.10	3.06	0.61	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	59.27	3.82	2.39	1.43	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	52.11	1.55	3.10	1.55	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	45.77	1.53	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	50.40	3.88	2.77	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	53.22	2.12	1.85	1.32	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	49.07	1.82	1.45	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	41.39	0.86	1.11	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	6.68	1.54	1.20	1.03	0.00
Astrocyte - cerebellum, donor3	11661-122F5	9.23	0.42	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	262.14	4.53	4.18	1.74	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	121.33	3.40	3.40	1.62	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	134.39	3.43	2.68	0.75	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	275.36	5.62	4.59	1.03	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	249.81	4.01	5.64	0.88	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	261.73	5.12	6.60	1.02	0.80
Basophils, donor1	12241-129G9	46.03	3.40	1.31	0.26	0.00
Basophils, donor2	12242-129H1	206.01	19.12	17.32	5.05	0.36
Basophils, donor3	12243-129H2	99.66	3.38	3.09	1.47	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	9.49	0.65	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.07	5.02	5.02	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	4.57	1.25	1.87	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	8.29	0.46	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	57.58	0.90	1.98	0.36	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	258.67	2.68	1.55	0.41	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	268.31	2.56	3.03	0.23	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	114.80	3.84	3.20	1.92	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	258.55	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	123.98	2.82	4.51	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	82.59	5.01	3.16	0.93	0.93
CD14+ Monocytes, donor3	11381-118B4	72.67	4.39	2.41	1.10	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	115.48	0.28	1.13	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	133.81	1.14	1.90	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	127.55	0.99	1.31	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	104.08	1.01	1.73	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	93.24	1.81	0.60	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	98.31	1.18	0.47	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	62.10	0.50	1.67	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	61.00	0.83	1.10	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	83.06	0.99	1.24	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	44.06	0.59	0.78	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	47.36	0.53	0.89	0.18	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	107.07	1.09	0.44	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	55.02	0.94	1.40	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	70.23	3.70	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	66.56	2.22	2.22	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	83.89	1.49	0.74	0.00	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	105.96	1.20	1.20	0.60	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	160.11	2.29	1.46	1.04	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	77.10	0.69	1.37	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	104.73	1.58	1.81	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	79.44	3.49	1.31	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.94	0.81	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.62	0.52	1.05	0.35	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	86.69	0.42	0.84	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	65.40	0.55	0.37	0.55	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	56.01	3.17	0.70	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	69.32	0.00	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	50.22	0.70	1.05	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	65.04	1.12	0.37	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	117.26	1.51	0.86	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	67.16	2.46	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	84.14	0.70	0.93	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	104.40	1.39	0.46	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	164.78	1.53	0.65	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	113.19	0.92	0.92	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	124.77	0.65	0.00	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	148.25	0.47	1.09	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	130.11	1.05	0.52	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	235.90	1.34	1.78	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	114.32	0.26	0.51	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	121.86	0.66	0.44	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	167.17	1.47	1.47	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	233.72	4.06	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	281.36	4.07	4.07	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	289.97	1.04	3.11	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	343.28	3.73	6.40	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	323.25	8.58	6.43	2.68	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	281.48	4.21	4.91	2.81	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	225.11	2.35	6.27	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	309.80	0.00	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	185.75	9.86	5.75	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	190.79	6.53	4.35	5.08	0.00
CD19+ B Cells, donor3	11705-123B4	180.73	4.54	3.03	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	228.29	12.93	14.95	5.25	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	149.81	7.99	6.39	3.99	0.40
CD34+ Progenitors, donor1	11545-120B6	67.27	2.01	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	133.71	10.11	5.06	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	126.25	3.38	2.63	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	163.70	2.48	2.48	1.80	0.00
CD4+ T Cells, donor1	11225-116C1	305.64	15.35	13.57	6.07	0.00
CD4+ T Cells, donor2	11306-117C1	146.35	12.25	5.51	4.90	1.22
CD4+ T Cells, donor3	11382-118B5	151.89	10.37	7.32	3.35	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	233.03	3.57	4.85	1.28	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	237.85	4.49	5.61	2.02	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	227.38	7.19	4.89	2.30	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	216.19	1.42	4.74	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	205.08	4.92	3.51	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	171.40	6.59	6.59	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	224.87	3.76	3.90	0.87	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	143.03	3.22	4.41	1.53	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	139.60	2.90	2.74	1.29	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	184.25	4.03	3.14	2.69	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	219.42	3.84	3.84	2.45	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	323.83	6.60	5.72	1.76	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	255.94	4.22	2.11	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	151.67	1.66	2.91	1.66	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	124.30	0.67	2.67	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	263.78	4.62	7.61	2.99	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	307.63	10.18	6.43	2.68	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	213.39	10.76	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	285.56	5.75	3.89	2.23	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	221.82	5.85	5.20	0.65	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	218.14	6.30	5.04	1.89	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	208.31	8.09	6.07	2.02	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	236.99	6.07	9.10	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	439.30	10.02	10.90	5.23	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	282.08	12.37	9.90	4.45	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	271.42	12.00	12.92	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	266.60	11.17	12.56	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	352.53	13.29	13.57	5.26	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	421.09	21.84	22.09	8.83	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	277.20	21.56	7.70	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	324.45	18.62	14.68	2.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	290.85	29.08	19.39	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	306.11	21.94	18.99	7.53	1.96
CD8+ T Cells, donor2	11307-117C2	163.69	19.52	8.63	6.01	3.00
CD8+ T Cells, donor3	11383-118B6	204.26	12.37	16.16	2.78	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.77	1.38	0.69	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.30	0.24	1.44	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	38.85	0.82	0.82	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	61.24	0.60	0.30	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	34.56	0.96	0.48	0.96	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	41.38	0.68	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.67	1.30	0.87	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.85	1.05	0.26	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	49.48	1.17	0.70	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	65.21	0.60	0.60	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	53.45	1.16	0.87	0.29	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.02	0.80	0.53	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	44.65	0.44	0.44	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	49.19	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	1.49	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	37.82	1.44	0.36	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.53	0.86	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.00	1.18	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	62.75	1.58	0.63	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	48.29	1.54	0.92	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	52.90	0.64	0.32	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	51.25	0.38	0.38	1.15	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	42.56	0.00	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	46.14	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	68.25	0.80	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	68.54	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	59.10	0.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	149.87	7.31	7.31	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	103.26	6.92	4.94	1.98	1.48
Cardiac Myocyte, donor3	11686-122I3	202.05	19.05	11.05	3.26	0.00
Chondrocyte - de diff, donor1	11261-116G1	165.01	5.55	4.51	1.39	1.04
Chondrocyte - de diff, donor2	11338-117F6	62.90	1.78	0.71	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	55.41	1.48	1.82	0.68	0.57
Chondrocyte - re diff, donor2	11339-117F7	177.26	6.27	5.37	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.04	1.21	1.62	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	175.81	2.41	2.87	1.26	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	79.95	1.71	1.92	0.43	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	83.19	1.59	2.92	0.80	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	66.21	4.68	5.04	1.93	0.28
Corneal Epithelial Cells, donor1	11526-119I5	6.37	0.22	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	14.79	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	0.51	1.53	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	127.45	4.13	3.80	1.32	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	120.49	5.68	1.89	1.58	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	100.07	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	77.86	3.46	1.73	1.30	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	146.91	10.25	3.07	3.42	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	132.53	10.45	4.57	3.92	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	121.95	10.65	8.71	3.87	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	30.35	1.83	2.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	20.64	1.98	1.41	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	1.18	2.36	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	34.90	3.20	2.04	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	59.76	2.59	3.29	1.18	0.94
Endothelial Cells - Artery, donor3	11413-118E9	29.10	2.80	2.28	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	113.71	2.22	2.66	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	132.66	4.26	3.96	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	150.54	2.82	3.95	1.41	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	25.55	0.59	2.67	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	1.04	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	16.02	1.13	1.56	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	101.63	4.40	7.60	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	1.05	2.62	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	231.47	7.83	9.69	2.36	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	74.30	5.21	7.60	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	100.27	8.18	11.11	1.22	0.12
Endothelial Cells - Vein, donor1	11267-116G7	18.20	0.00	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	2.10	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.62	0.94	2.51	0.16	0.31
Eosinophils, donor1	12244-129H3	213.46	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	404.31	18.15	19.80	9.90	0.00
Eosinophils, donor3	12246-129H5	360.25	7.13	24.97	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.11	0.00	0.98	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	139.57	12.73	6.57	3.28	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.90	2.85	2.19	1.20	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	62.40	3.68	2.38	1.08	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	151.11	6.31	4.37	1.21	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	158.72	5.73	7.10	2.87	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	81.21	5.70	3.16	2.00	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	137.54	4.22	3.43	1.58	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	131.55	3.32	3.65	2.99	1.33
Fibroblast - Cardiac, donor1	11268-116G8	58.52	5.90	4.08	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	34.87	4.55	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	35.96	1.42	1.89	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	297.65	29.10	20.31	3.64	0.00
Fibroblast - Cardiac, donor5	11456-119A7	93.27	4.70	2.92	1.40	0.63
Fibroblast - Cardiac, donor6	11460-119B2	110.97	8.79	4.85	1.36	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.17	2.55	2.14	1.21	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	88.01	3.02	1.29	1.29	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	90.82	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.21	1.38	0.69	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	180.46	2.88	2.20	1.70	0.00
Fibroblast - Dermal, donor1	11269-116G9	56.58	2.58	4.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	32.07	4.25	3.30	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	66.49	1.57	1.93	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	102.76	3.28	4.52	0.79	0.34
Fibroblast - Dermal, donor5	11454-119A5	89.32	4.71	4.01	0.87	0.70
Fibroblast - Dermal, donor6	11458-119A9	116.46	5.04	5.85	2.11	0.49
Fibroblast - Gingival, donor1	11237-116D4	168.87	3.12	4.58	0.62	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	131.00	5.50	6.55	2.62	0.00
Fibroblast - Gingival, donor2	11318-117D4	113.86	3.29	3.82	1.32	0.66
Fibroblast - Gingival, donor3	11394-118C8	127.05	1.74	2.80	1.06	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	135.06	2.08	4.16	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.10	3.35	1.76	1.23	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	134.69	4.52	6.24	2.81	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	138.61	5.81	5.41	2.16	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.41	2.47	2.82	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	123.72	5.12	3.95	1.32	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	142.49	5.86	4.36	2.05	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	154.34	6.03	7.46	1.97	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	109.32	1.76	2.64	1.17	0.29
Fibroblast - Lung, donor1	11270-116H1	6.80	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	162.64	1.49	8.95	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	55.50	1.06	2.74	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	2.50	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.52	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	42.63	1.62	1.62	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	192.42	4.07	5.63	1.75	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	135.76	5.46	6.22	1.97	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	249.69	9.49	6.73	1.84	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	106.09	3.05	2.67	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	74.79	1.89	2.43	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.30	2.55	1.74	0.81	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	163.59	5.64	5.42	1.33	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.98	1.63	1.83	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	0.00	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	69.19	2.37	3.56	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	226.23	5.16	4.37	1.59	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	151.69	4.44	3.55	2.13	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	183.88	12.02	7.29	3.55	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	122.75	2.41	3.01	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	174.99	6.59	5.40	2.70	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	173.61	4.30	4.56	3.54	1.52
Fibroblast - skin normal, donor1	11553-120C5	150.30	5.09	4.10	1.48	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	241.81	4.41	8.02	1.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	190.17	5.42	6.33	1.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	243.00	3.93	4.23	1.21	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	189.72	6.38	3.56	2.90	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	219.50	8.38	5.30	6.67	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	157.32	4.60	4.93	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	199.62	3.52	6.28	2.88	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	103.74	3.37	3.88	1.18	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	130.47	3.45	2.98	1.25	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2991.57	88.64	66.48	22.16	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	97.61	4.36	4.36	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	87.72	4.85	4.33	2.25	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	105.66	9.11	6.77	1.30	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	97.35	10.73	8.18	1.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	57.42	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	74.02	1.91	2.55	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	156.90	7.13	5.42	2.00	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	95.41	1.10	1.38	0.28	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	116.45	0.91	1.37	0.68	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	109.76	2.38	3.57	0.79	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	85.38	0.53	0.79	0.26	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	75.34	0.98	0.00	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	106.58	3.10	3.54	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	111.08	2.69	2.69	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	82.38	1.60	2.09	1.11	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	88.38	2.15	1.07	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	102.46	3.10	3.10	0.50	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	96.90	2.08	2.77	1.66	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	96.37	2.85	2.85	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	99.26	1.60	1.60	0.68	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	83.96	2.62	1.74	0.62	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	70.60	1.97	2.19	1.53	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	100.17	1.18	1.48	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	92.35	2.54	2.86	1.11	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	89.14	2.90	2.23	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	109.49	1.61	2.02	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	140.80	1.36	2.21	1.02	2.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	198.18	3.28	2.57	1.51	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	199.48	0.52	0.83	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	228.50	0.85	1.20	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	123.16	1.55	1.44	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	176.96	3.24	2.08	1.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	194.79	2.45	0.82	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	134.92	1.86	0.62	0.83	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	113.68	2.19	1.04	0.23	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	109.56	2.67	2.17	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	95.01	0.66	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	128.40	0.86	1.60	0.37	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	109.41	1.62	1.62	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	99.42	0.32	0.32	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	92.67	1.14	1.14	0.95	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	99.18	0.95	1.42	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	128.32	0.61	0.30	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	106.63	1.36	1.15	0.42	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	88.48	1.10	0.66	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	108.01	0.84	1.68	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	87.31	1.94	2.22	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	107.50	2.41	1.60	0.80	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	106.19	1.68	2.30	0.46	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	80.96	1.68	2.07	0.65	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	83.76	1.90	1.08	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	120.38	1.84	2.77	0.92	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	128.96	1.75	1.54	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	146.78	0.99	5.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	120.30	1.58	1.71	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	97.05	2.02	1.01	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	231.03	1.27	3.30	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	174.77	4.58	2.19	1.79	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	86.90	1.85	2.16	0.77	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	123.16	2.05	2.25	1.02	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	77.29	0.94	2.50	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	83.07	0.57	1.41	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	66.41	0.92	1.38	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	160.86	0.00	2.47	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	143.89	1.16	1.16	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	123.54	3.21	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	0.00	1.74	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	139.96	2.93	2.28	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	168.02	2.47	0.82	0.41	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	99.97	10.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	152.97	5.03	1.96	0.28	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	145.45	3.60	1.31	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	124.99	2.52	2.52	0.84	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	173.35	4.77	2.54	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	138.24	1.36	3.40	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	215.08	4.18	0.00	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	172.38	4.01	2.29	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	100.93	2.96	3.26	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	279.53	6.78	1.69	1.69	10.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	256.81	8.28	4.14	2.90	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	195.61	4.37	2.53	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	242.35	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	180.29	7.69	3.46	1.54	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	231.76	8.48	4.56	0.98	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	210.02	4.68	1.34	0.67	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	263.52	5.39	3.47	0.39	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	217.73	9.24	3.08	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	258.42	14.91	2.48	0.00	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	180.25	4.25	2.36	0.47	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	182.86	6.03	2.41	0.60	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	241.11	2.54	1.53	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	225.74	4.79	2.39	1.20	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	272.83	6.41	1.97	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	205.40	2.36	5.90	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	235.13	7.00	3.50	0.58	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	224.71	4.39	2.19	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	189.88	5.93	0.85	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	118.19	2.98	0.00	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	181.00	2.43	0.00	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	52.81	1.66	0.83	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	2.25	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	106.25	2.54	2.22	1.90	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	64.33	4.18	3.76	2.92	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	64.64	3.48	2.90	1.74	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	69.88	6.08	3.54	1.52	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	72.35	3.87	5.46	1.59	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	67.44	3.17	5.47	1.53	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.71	4.73	2.58	2.58	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	63.94	3.44	5.38	2.15	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.28	3.36	4.23	1.12	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	68.45	4.97	3.43	1.54	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	68.24	3.52	1.60	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.87	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.16	1.06	2.47	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	1.45	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	81.47	2.97	1.92	1.40	1.75
Hepatocyte, donor1	11523-119I2	46.00	0.00	1.21	1.21	1.21
Hepatocyte, donor2	11603-120I1	62.49	4.31	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	79.76	3.68	1.84	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	112.91	5.22	3.92	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	167.79	2.27	2.10	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	116.63	4.39	3.29	1.78	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	1.63	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	5.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.19	0.47	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	1.08	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.64	0.00	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	77.52	3.43	3.84	1.14	0.24
Keratinocyte - epidermal, donor2	11349-117G8	6.44	0.59	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	91.53	2.08	2.65	0.47	1.14
Keratinocyte - oral, donor1	11251-116E9	171.87	2.84	4.88	0.79	0.45
Keratocytes, donor1	11527-119I6	38.51	0.00	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	5.86	2.34	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	59.67	0.59	0.59	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	4.40	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	84.14	3.24	1.08	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	141.86	1.27	1.73	1.15	0.00
Lens Epithelial Cells, donor3	11690-122I7	133.71	4.04	4.74	1.21	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.51	1.78	2.02	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.95	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	46.91	1.57	4.25	0.16	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	1.08	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	0.32	0.63	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.19	0.32	0.54	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.11	1.64	2.46	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.29	0.76	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	0.14	0.70	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	40.34	0.79	1.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.68	0.00	1.36	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.55	0.19	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.09	0.35	1.39	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.74	0.72	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.06	0.55	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	39.73	2.46	0.92	0.00	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.55	0.00	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.06	0.37	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	28.63	0.33	0.99	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	0.29	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	49.95	0.97	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.16	1.08	1.35	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.62	0.45	0.45	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	0.52	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.13	1.26	1.68	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.68	0.30	0.90	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.14	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.34	0.75	0.75	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.38	0.21	0.53	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.16	1.94	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	0.33	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.58	0.12	0.62	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	58.86	1.48	2.22	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.48	0.74	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.77	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	38.60	0.64	1.93	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.87	1.22	1.83	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.43	0.56	1.82	0.14	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.82	0.36	1.42	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.20	0.00	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	0.72	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.39	0.98	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	38.36	1.36	0.99	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	0.77	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.55	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	0.00	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.96	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	10.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	22.16	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	15.61	0.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	36.35	0.58	1.16	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.12	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.96	0.41	0.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.76	0.35	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	32.65	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.39	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	44.82	0.80	0.00	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	48.37	0.00	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.11	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	29.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	52.48	0.62	0.62	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	38.40	0.00	0.00	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	19.58	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.06	0.58	0.00	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	0.30	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.41	1.11	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	31.46	0.35	0.71	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.81	0.74	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.19	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	0.00	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.21	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.57	0.00	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	21.41	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.66	0.33	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.62	0.69	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.26	0.37	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	29.21	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	11.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.83	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.37	0.00	0.89	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	1.32	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.01	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	1.31	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.60	1.12	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	17.67	0.44	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	2.31	0.00	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	0.51	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	28.62	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	14.53	0.00	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.94	0.38	0.00	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.56	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	9.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	33.59	0.32	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	0.57	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.05	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.69	1.25	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.73	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	15.50	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.59	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	10.67	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.96	1.14	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.58	0.00	0.78	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	10.61	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	111.22	1.60	2.51	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	93.04	3.30	4.22	4.40	0.00
Macrophage - monocyte derived, donor3	11389-118C3	69.87	2.88	2.23	1.44	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	77.00	9.03	4.25	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	194.42	9.03	5.39	1.74	0.48
Mallassez-derived cells, donor3	11930-125I4	165.53	8.62	7.78	1.39	0.00
Mammary Epithelial Cell, donor1	11273-116H4	184.04	2.49	2.89	1.59	1.10
Mammary Epithelial Cell, donor2	11350-117G9	149.12	4.63	2.32	1.16	0.58
Mammary Epithelial Cell, donor3	11422-118F9	12.47	0.75	0.75	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	1071.14	12.88	9.49	3.39	0.68
Mast cell, donor1	11563-120D6	277.16	2.05	1.84	0.22	0.22
Mast cell, donor2	11565-120D8	226.74	0.89	2.67	2.67	0.00
Mast cell, donor3	11566-120D9	249.21	2.25	1.80	2.03	0.00
Mast cell, donor4	11567-120E1	195.55	0.53	1.95	2.30	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	259.93	2.99	2.66	0.89	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	203.71	4.09	2.92	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	214.19	0.80	0.80	0.46	0.34
Mast cell, expanded, donor8	11941-126A6	246.53	2.34	3.18	0.67	0.67
Melanocyte - dark, donor1	11502-119F8	101.99	4.78	5.77	1.09	0.20
Melanocyte - dark, donor2	11582-120F7	134.63	5.19	5.54	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	194.94	1.59	1.30	1.30	0.80
Melanocyte - light, donor1	11274-116H5	21.39	0.24	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.92	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.95	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	97.15	3.02	1.87	0.31	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	65.89	3.77	1.34	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	107.14	2.14	2.68	1.07	0.27
Meningeal Cells, donor1	11493-119E8	56.08	2.11	3.97	0.62	0.00
Meningeal Cells, donor2	11573-120E7	27.29	0.44	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	237.25	4.89	5.54	2.04	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	140.87	2.85	3.99	1.14	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	113.01	5.43	3.42	1.51	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	86.83	0.72	0.72	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	105.46	3.81	3.39	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	80.93	2.01	5.53	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	26.15	2.42	0.88	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	12.42	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.87	1.02	0.82	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	141.00	3.05	2.77	2.22	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.39	1.49	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	263.81	14.47	4.61	1.97	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	0.89	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	159.50	2.48	3.90	2.13	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	216.09	9.38	4.69	2.50	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	55.88	1.45	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	102.09	6.36	5.30	3.18	0.27
Mesothelial Cells, donor2	12156-128G5	61.56	9.01	7.01	2.50	0.50
Mesothelial Cells, donor3	11402-118D7	76.74	5.56	4.19	2.17	1.73
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	54.01	2.70	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	78.81	2.96	2.71	4.93	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.24	5.89	1.47	3.24	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	68.81	2.79	2.17	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	44.18	3.32	4.56	3.32	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	65.82	2.50	1.00	1.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.82	4.65	4.19	4.19	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	59.54	2.03	2.03	1.02	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	31.68	4.75	0.79	1.98	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	1.77	1.77	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.41	2.66	3.42	1.52	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	2.63	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	49.87	1.27	0.85	2.33	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	0.92	4.60	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.44	2.38	1.19	1.49	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	5.03	6.71	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	49.18	2.01	1.51	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.74	2.85	2.38	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	15.48	4.98	2.21	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	59.63	2.07	1.61	0.46	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	41.02	4.42	2.10	2.31	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	47.90	2.24	1.43	1.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	69.08	1.07	0.86	3.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.56	4.45	2.22	2.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.77	2.41	1.31	1.75	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	21.29	4.06	4.56	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	4.97	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	49.47	2.17	1.63	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	31.76	2.06	3.82	1.76	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	1.09	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	29.31	0.96	1.92	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.42	3.20	2.00	2.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	41.05	1.50	1.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	2.04	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	47.73	3.07	1.31	2.19	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	5.52	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	5.76	2.56	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	85.04	3.47	0.99	1.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	4.18	2.78	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	6.63	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	89.23	2.74	3.08	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	3.94	4.81	2.19	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	24.86	3.20	2.84	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	70.70	2.52	0.28	1.68	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	4.16	3.74	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.89	3.50	2.91	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	45.25	2.11	1.51	1.81	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	46.75	2.92	3.76	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	71.11	5.54	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	38.70	4.55	3.98	3.98	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	48.09	1.24	1.52	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	70.49	3.11	1.04	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	41.61	2.57	4.29	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	1.27	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	51.78	2.94	1.60	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	49.99	4.49	3.59	2.39	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	36.30	0.42	1.27	0.71	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	64.34	1.27	0.32	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	59.71	3.32	4.86	1.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	24.27	1.90	1.52	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	84.10	3.69	0.57	1.99	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	67.60	2.46	1.72	2.70	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.81	1.30	1.30	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	69.68	1.76	1.18	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	58.82	3.75	1.73	1.44	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	116.22	2.89	2.06	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	58.96	2.08	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	67.80	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	1.78	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	74.59	0.66	0.99	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	46.29	3.16	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	77.30	1.38	0.79	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	61.47	0.93	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	73.98	1.13	2.25	1.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.69	1.60	2.66	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	98.06	0.57	0.57	0.79	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.86	0.37	0.37	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	76.22	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	109.03	1.60	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	56.50	0.84	1.69	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	92.61	2.72	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	70.57	0.00	1.27	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	89.89	0.00	0.00	2.43	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	40.78	0.00	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	146.81	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	133.57	9.26	7.76	2.59	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	105.57	3.14	3.66	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.70	1.33	2.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.37	2.50	3.34	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	134.62	2.28	4.18	1.90	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	81.39	6.38	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.04	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	494.33	1.84	7.35	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	1.67	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	34.40	2.09	3.25	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.00	0.54	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	74.84	2.31	1.26	0.63	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1258.22	0.00	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	34.25	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	54.40	3.25	2.17	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	39.22	1.81	2.04	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	29.72	1.47	1.14	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	90.40	1.46	2.00	1.64	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	33.95	2.12	2.65	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	1.80	1.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	162.78	1.97	4.27	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.82	1.30	2.60	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	87.49	3.00	2.12	0.53	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.24	3.52	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.53	4.14	1.38	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.49	1.29	1.61	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	184.52	6.21	7.24	3.45	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	384.32	30.34	7.59	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	69.06	3.12	1.56	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	28.37	1.27	3.39	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.86	3.80	1.90	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.48	2.58	2.15	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1272.91	18.06	9.03	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	32.32	3.33	1.67	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	39.68	0.90	2.25	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.57	2.38	0.79	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	2.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	57.89	4.16	1.89	3.03	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.12	1.63	0.98	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	2.18	1.31	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	79.60	2.71	5.43	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	1.76	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.90	1.99	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	44.64	0.99	1.49	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.52	3.06	2.30	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	86.50	3.93	2.12	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	79.13	3.09	3.32	2.65	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	4.74	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	822.63	15.33	25.55	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	37.80	1.22	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.09	3.78	1.89	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.19	1.82	0.30	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	0.00	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	180.25	13.60	9.07	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	859.84	15.17	5.06	5.06	10.12
Myoblast, donor1	11241-116D8	107.33	5.71	4.22	1.74	0.75
Myoblast, donor2	11322-117D8	79.40	3.84	2.69	2.30	0.77
Myoblast, donor3	11398-118D3	154.04	5.04	6.73	1.01	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	174.54	1.90	1.75	0.58	0.29
Natural Killer Cells, donor1	11230-116C6	308.44	22.14	20.30	4.61	0.00
Natural Killer Cells, donor2	11311-117C6	171.28	17.79	15.08	4.82	2.41
Natural Killer Cells, donor3	11387-118C1	191.60	16.20	16.56	3.50	2.02
Neural stem cells, donor1	11275-116H6	562.56	7.98	3.99	2.90	0.00
Neural stem cells, donor2	11352-117H2	498.74	9.63	1.93	1.93	0.00
Neurons, donor1	11494-119E9	209.37	6.83	1.14	0.00	2.28
Neurons, donor2	11574-120E8	257.37	2.20	2.42	1.54	0.44
Neurons, donor3	11655-122E8	231.03	3.29	2.47	1.64	0.82
Neutrophils, donor1	11233-116C9	456.58	10.21	3.71	3.71	1.86
Neutrophils, donor2	11314-117C9	284.09	2.90	8.70	0.00	2.90
Neutrophils, donor3	11390-118C4	677.42	18.33	15.88	7.33	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	172.17	0.59	1.78	1.90	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	39.07	0.33	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	55.75	1.40	1.00	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	84.79	4.27	3.44	2.20	1.24
Olfactory epithelial cells, donor2	11934-125I8	132.15	7.09	3.91	2.32	3.33
Olfactory epithelial cells, donor3	11935-125I9	106.81	8.51	6.47	4.43	0.91
Olfactory epithelial cells, donor4	11936-126A1	106.07	5.75	4.97	2.92	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	158.28	4.81	3.61	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	41.05	2.77	1.49	1.49	0.00
Osteoblast - differentiated, donor2	11353-117H3	19.43	1.14	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	36.62	0.62	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	12.31	1.17	0.98	0.00	0.00
Osteoblast, donor2	11354-117H4	193.84	3.51	5.62	0.70	0.70
Osteoblast, donor3	11426-118G4	29.15	1.96	1.60	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	180.60	3.37	3.54	1.77	0.84
Pericytes, donor1	11491-119E6	10.57	0.00	0.22	0.00	0.00
Pericytes, donor2	11571-120E5	6.79	0.23	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	14.65	1.42	1.63	0.41	0.20
Perineurial Cells, donor1	11499-119F5	151.11	4.29	3.96	0.11	0.34
Perineurial Cells, donor2	11579-120F4	228.46	12.15	8.37	2.48	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	252.76	8.29	7.33	2.23	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	127.08	6.37	3.92	1.96	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	120.49	8.80	6.60	1.29	0.26
Placental Epithelial Cells, donor1	11278-116H9	30.61	0.24	0.96	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	44.36	2.22	0.00	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.20	0.59	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	51.90	1.90	1.90	1.27	0.32
Preadipocyte - breast, donor1	11467-119B9	120.06	5.25	4.13	2.63	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	217.98	10.18	5.22	2.61	0.13
Preadipocyte - breast, donor2	11328-117E5	76.78	4.50	5.18	1.13	1.58
Preadipocyte - omental, donor1	11468-119C1	139.59	16.30	8.84	5.01	0.32
Preadipocyte - omental, donor2	11329-117E6	151.02	8.73	8.29	3.06	0.00
Preadipocyte - omental, donor3	11403-118D8	107.44	10.46	7.16	2.44	0.14
Preadipocyte - perirenal, donor1	11469-119C2	32.48	5.91	5.91	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	28.87	3.69	0.92	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	132.45	5.67	3.19	1.24	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	96.89	3.41	3.41	1.19	0.51
Preadipocyte - visceral, donor1	11280-116I2	217.13	5.03	3.82	1.49	0.19
Preadipocyte - visceral, donor2	11357-117H7	112.28	2.30	2.76	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	84.64	2.30	3.55	0.63	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	138.48	2.41	2.26	1.21	0.30
Prostate Epithelial Cells, donor2	11331-117E8	53.22	2.84	3.25	0.81	0.54
Prostate Epithelial Cells, donor3	11404-118D9	47.89	0.55	0.80	0.24	0.49
Prostate Stromal Cells, donor1	11254-116F3	107.29	3.30	3.76	1.37	0.57
Prostate Stromal Cells, donor2	11332-117E9	76.56	5.20	3.23	1.26	1.26
Prostate Stromal Cells, donor3	11405-118E1	88.01	4.17	3.13	1.88	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	15.33	0.73	1.09	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	114.71	2.70	2.77	0.69	0.28
Renal Epithelial Cells, donor1	11517-119H5	3.04	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.71	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	164.73	3.81	3.81	1.27	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.34	1.35	1.21	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	95.91	6.22	7.33	0.22	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	25.31	0.00	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.15	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.50	1.07	1.88	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.80	0.77	0.77	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	99.05	1.81	2.59	1.30	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.49	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	3.09	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	66.49	0.75	0.50	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	178.94	4.81	2.00	1.60	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	104.53	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	314.81	1.65	2.75	1.65	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	240.72	2.32	2.32	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	167.08	6.76	5.85	0.91	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	91.96	2.58	2.28	0.79	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	197.31	5.13	3.68	1.56	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	189.41	5.21	5.58	2.73	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	105.24	2.91	3.03	0.70	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	152.78	4.39	2.77	0.92	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	100.22	4.24	4.11	1.10	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	122.83	3.48	2.57	0.91	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	136.36	4.30	3.40	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	97.26	3.59	4.45	1.29	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	95.40	2.47	3.43	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	108.20	4.20	3.54	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	108.78	4.01	3.82	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	97.17	2.24	3.63	2.24	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	224.55	7.70	4.32	2.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	95.95	3.98	4.11	1.86	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	107.46	3.02	3.21	1.75	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	134.63	5.16	4.20	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	98.04	3.31	3.20	2.67	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	108.48	3.08	2.24	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	111.08	3.59	2.39	1.54	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	91.89	5.65	4.01	1.82	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	94.92	3.43	2.82	1.47	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	112.02	4.03	4.57	2.55	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	120.06	4.72	3.54	1.42	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	100.20	1.98	2.78	1.98	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	129.08	2.57	3.04	2.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	100.36	5.18	2.49	1.04	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	126.53	3.54	1.99	1.55	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	86.48	3.13	3.55	2.92	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	100.13	4.44	5.65	1.62	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	102.86	3.92	3.41	2.90	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	94.47	3.86	3.08	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	128.09	4.99	3.61	2.24	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	88.89	1.92	3.15	2.06	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	138.07	3.94	2.30	1.31	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	106.69	3.41	3.41	1.70	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	122.21	2.81	3.40	0.89	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	98.89	3.47	4.00	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	96.10	2.21	1.38	1.38	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	89.76	1.43	2.38	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	147.13	4.23	2.22	2.02	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	87.02	1.79	1.04	1.13	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	123.67	0.70	1.05	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	97.92	1.21	1.51	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	80.04	1.59	1.47	0.49	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	328.66	3.93	4.80	2.04	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	128.38	0.00	2.43	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	94.64	2.41	1.81	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	74.19	0.90	2.04	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	117.12	1.50	2.10	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	87.49	1.89	1.18	0.59	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.93	2.56	1.71	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	96.76	1.20	1.80	0.00	0.60
Schwann Cells, donor1	11498-119F4	8.65	0.56	0.38	0.19	0.38
Schwann Cells, donor2	11578-120F3	74.85	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	77.34	1.97	2.19	0.44	2.85
Sebocyte, donor1	11220-116B5	41.63	0.55	2.74	0.00	0.00
Sebocyte, donor2	11301-117B5	26.19	0.00	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	20.41	1.03	1.44	0.21	0.00
Sertoli Cells, donor1	11255-116F4	233.58	9.94	4.97	4.97	0.00
Sertoli Cells, donor2	11333-117F1	124.27	31.07	0.00	14.12	0.00
Skeletal Muscle Cells, donor1	11281-116I3	90.97	0.88	1.14	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	0.00	0.84	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	80.12	3.93	2.67	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	67.78	1.93	2.23	0.74	0.59
Skeletal Muscle Cells, donor6	11459-119B1	92.96	4.00	4.77	0.92	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	200.85	2.77	3.65	1.01	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	85.19	2.43	2.14	1.14	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	95.24	4.56	5.06	0.99	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	118.37	3.54	4.13	1.43	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.66	0.14	0.41	0.28	0.00
Skin - palm, donor1	10286-104F7	75.21	2.69	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	35.46	1.87	0.72	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	179.12	10.63	5.73	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	34.27	0.78	0.52	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	99.81	2.36	1.67	0.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	51.06	2.39	1.41	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	201.51	4.65	4.02	2.54	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	35.98	0.82	1.05	0.37	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	69.74	2.47	2.16	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	115.61	3.11	2.22	1.33	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.14	2.94	3.53	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	41.10	0.66	0.44	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	26.38	2.36	1.97	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	63.35	5.41	4.64	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	135.10	2.00	0.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	56.69	2.13	1.86	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	102.63	6.43	2.88	2.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	52.75	3.46	2.56	0.64	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	116.89	1.95	2.93	1.63	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	140.57	7.09	5.91	3.25	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	65.20	10.11	5.84	2.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.37	0.00	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	94.07	2.44	1.52	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	36.62	1.77	0.76	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	133.91	11.80	8.70	1.92	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	100.52	5.17	3.23	0.65	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	89.21	3.25	2.41	0.94	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	29.08	0.93	0.93	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	30.18	4.31	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.92	2.69	1.49	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.78	1.02	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	193.73	2.12	1.57	0.79	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	152.37	9.76	7.45	2.42	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.58	2.50	2.05	0.46	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.11	1.21	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	189.69	9.27	8.74	2.65	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	150.60	5.33	5.06	1.33	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	115.70	11.39	6.76	2.25	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	108.57	3.04	3.04	2.28	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	96.65	2.86	2.71	0.90	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.01	0.75	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	62.03	1.29	0.00	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	28.37	3.26	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	51.50	3.03	3.53	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	23.82	3.76	1.88	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	0.29	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	167.28	4.33	4.83	1.67	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	80.82	2.80	2.34	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.03	2.30	2.01	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.87	3.06	1.53	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.73	0.38	0.75	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	198.72	3.63	3.35	1.40	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	123.92	3.02	3.02	1.01	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.00	2.45	1.71	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	137.21	11.71	5.52	3.54	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	101.82	2.34	2.93	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	88.24	1.94	1.75	1.36	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	93.62	7.40	2.12	2.38	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	236.56	4.84	2.98	2.98	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	136.91	15.45	8.98	5.03	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	63.59	6.25	3.97	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	119.34	7.09	3.54	1.97	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	135.86	5.08	4.32	1.02	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	105.42	2.40	3.19	2.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	102.83	9.61	4.18	3.34	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	102.21	6.88	4.13	0.92	1.83
Synoviocyte, donor1	11291-117A4	224.20	16.33	7.41	4.54	1.01
Synoviocyte, donor2	11368-117I9	68.22	1.51	2.85	0.67	0.17
Synoviocyte, donor3	11440-118H9	62.11	1.12	1.79	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	29.30	1.79	0.71	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	28.25	1.16	1.39	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	49.89	1.51	1.94	0.65	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	0.57	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	173.59	2.95	2.95	1.11	0.25
Urethra, donor2	10319-105A4	95.32	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	7.17	0.27	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	8.41	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.42	0.00	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	121.03	3.12	4.24	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	329.22	8.90	9.79	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	335.96	11.44	8.58	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	133.48	2.74	5.48	1.37	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	253.09	8.61	5.51	3.44	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	225.44	12.78	4.65	4.65	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	273.85	6.25	4.16	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	314.80	10.10	9.18	6.42	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	121.42	0.00	7.30	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	100.66	2.34	3.21	0.86	0.49
Wilms' tumor cell line:HFWT	10597-108E3	58.96	0.88	4.40	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	70.39	1.40	1.68	1.40	0.28
achilles tendon, donor2	10292-104G4	107.46	4.13	0.00	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	307.48	5.86	4.08	0.76	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	215.46	2.09	1.63	1.16	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	336.89	2.85	4.39	1.31	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	215.79	5.99	7.35	1.90	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	212.50	1.97	3.65	0.84	4.22
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	160.73	1.90	1.90	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	84.66	1.91	2.45	1.63	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	159.51	1.32	2.20	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	122.51	1.23	1.63	1.23	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	103.29	1.16	0.39	0.78	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	99.18	0.92	1.29	0.55	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	187.30	2.09	2.79	1.16	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	153.27	1.55	1.55	0.52	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	119.82	1.46	1.17	0.58	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	68.78	0.93	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	65.39	1.65	0.41	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.58	0.61	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	108.38	0.85	1.28	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	148.61	0.30	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	153.09	0.96	1.44	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	194.67	2.90	3.79	0.67	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	110.07	4.34	2.33	1.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	5.57	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	72.32	0.00	1.13	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	144.80	2.18	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	61.86	0.00	9.37	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	70.18	0.47	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	176.06	3.72	3.57	1.55	0.16
adipose, donor1	10184-103D4	288.51	0.59	2.35	1.17	4.10
adipose, donor2	10185-103D5	52.72	0.00	0.41	0.00	0.41
adipose, donor3	10186-103D6	127.43	1.09	1.09	0.00	0.27
adipose, donor4	10187-103D7	282.56	3.47	6.07	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	85.06	6.15	10.42	2.84	0.32
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.58	0.67	2.00	1.33	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	133.99	0.71	2.14	0.71	2.50
amniotic membrane cells, donor1	12235-129G3	94.36	2.78	2.78	3.01	0.46
amniotic membrane cells, donor2	12236-129G4	205.57	16.23	12.51	4.73	1.35
amniotic membrane cells, donor3	12237-129G5	81.90	3.24	4.71	2.06	0.59
amygdala - adult, donor10196	10167-103B5	422.14	27.27	35.57	10.67	2.37
amygdala, adult, donor10252	10151-102I7	509.15	28.39	16.02	6.89	1.42
amygdala, newborn, donor10223	10360-105E9	146.54	10.65	6.78	3.55	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	48.51	0.51	0.64	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	110.53	1.99	2.65	0.66	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	137.96	2.34	1.67	0.00	1.34
aorta, adult, pool1	10052-101G7	65.12	1.18	3.73	0.78	0.98
appendix, adult	10189-103D9	148.26	4.27	5.05	1.55	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	117.63	1.72	0.34	0.69	0.69
artery, adult	10190-103E1	93.75	1.36	2.72	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	334.64	3.48	1.59	1.01	0.43
b cell line:RPMI1788	10427-106D4	189.59	3.72	3.57	0.59	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	207.25	13.87	4.72	3.33	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	187.15	2.88	2.58	1.29	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	61.93	0.50	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	56.48	0.00	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	239.55	2.93	4.78	2.50	0.22
blood, adult, pool1	10053-101G8	73.08	0.00	4.43	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	111.33	2.57	2.57	3.43	0.00
bone marrow, adult	10192-103E3	175.45	2.70	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	120.96	7.18	8.20	5.13	2.05
brain, adult, pool1	10012-101C3	546.55	20.60	18.82	8.69	2.00
brain, fetal, pool1	10085-102B4	48.09	2.67	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	21.80	0.66	2.97	2.31	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	145.42	1.25	1.75	1.00	0.12
breast, adult, donor1	10080-102A8	72.61	3.79	3.16	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	133.90	2.67	1.40	0.89	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	78.85	0.62	0.93	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	187.86	5.99	4.37	0.92	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	88.85	1.21	2.42	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	161.27	1.41	1.88	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	108.83	0.88	0.77	0.22	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	106.16	0.95	1.27	0.00	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	150.12	2.66	2.13	1.33	1.06
caudate nucleus - adult, donor10196	10177-103C6	466.29	16.12	27.63	6.91	2.30
caudate nucleus, adult, donor10252	10164-103B2	384.35	19.91	14.89	7.03	1.67
caudate nucleus, adult, donor10258	10379-105H1	173.46	22.92	19.87	7.64	1.53
caudate nucleus, newborn, donor10223	10354-105E3	168.47	22.34	9.52	5.13	1.10
cerebellum - adult, donor10196	10173-103C2	541.87	8.74	5.83	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	522.46	7.47	8.11	2.99	1.28
cerebellum, adult, pool1	10083-102B2	179.72	3.10	1.03	1.38	1.72
cerebellum, newborn, donor10223	10357-105E6	357.85	8.30	5.81	3.32	0.83
cerebral meninges, adult	10188-103D8	258.95	26.98	19.67	7.31	1.01
cerebrospinal fluid, donor2	10294-104G6	84.78	6.58	8.77	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	114.31	1.01	1.01	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	122.80	1.66	0.50	0.17	0.00
cervix, adult, pool1	10013-101C4	238.12	3.25	3.15	2.62	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	82.77	1.67	0.98	1.67	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	40.49	6.53	11.76	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	156.96	3.73	4.97	2.11	0.50
choriocarcinoma cell line:SCH	10785-110H2	92.16	1.48	3.20	1.11	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	77.32	4.03	4.74	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	83.77	1.71	1.42	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	162.87	5.17	3.88	1.29	0.30
chorionic membrane cells, donor3	12240-129G8	111.55	1.10	2.20	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	120.17	6.06	3.03	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	110.26	2.69	1.73	0.96	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	76.66	1.69	0.84	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	64.20	1.54	1.80	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	74.01	1.21	0.97	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	80.02	2.44	1.63	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	67.14	2.94	2.36	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	175.92	1.82	4.43	0.78	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	105.60	3.89	3.89	1.37	1.14
clear cell carcinoma cell line:TEN	10636-108I6	135.86	2.95	1.56	0.69	0.35
colon carcinoma cell line:CACO-2	10513-107D9	160.16	3.11	4.39	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	168.38	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	36.89	0.00	1.19	0.00	2.38
colon, adult, pool1	10014-101C5	150.40	2.47	1.65	2.12	0.12
colon, fetal, donor1	10070-101I7	88.37	1.24	0.62	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	96.25	0.00	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	175.50	0.85	0.42	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	127.39	0.75	1.21	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	157.65	1.13	1.13	0.28	0.56
corpus callosum, adult, pool1	10042-101F6	518.21	22.33	9.29	3.98	0.55
cruciate ligament, donor2	10295-104G7	122.38	1.62	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	95.50	0.00	0.80	0.00	0.80
diencephalon, adult	10193-103E4	412.54	19.68	11.52	6.00	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	145.80	0.69	1.38	0.46	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	140.53	2.82	3.33	1.28	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	153.82	2.41	1.93	0.48	0.48
ductus deferens, adult	10196-103E7	86.71	1.50	1.50	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	93.61	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	183.18	4.41	4.41	2.21	2.94
dura mater, adult, donor1	10041-101F5	209.11	4.46	4.21	2.15	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	104.15	4.00	0.89	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	130.40	3.58	1.86	0.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	52.41	0.62	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	55.09	0.30	0.30	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	56.50	0.31	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	64.36	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	113.97	1.01	1.68	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	165.29	1.45	1.45	1.09	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	81.85	2.41	2.41	0.96	1.61
epidermoid carcinoma cell line:A431	10426-106D3	140.06	1.00	1.45	1.89	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	174.11	2.86	3.19	0.88	0.11
epididymis, adult	10197-103E8	130.19	2.72	2.72	1.47	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	144.94	0.53	1.06	0.89	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	67.24	3.93	1.97	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	107.33	1.83	2.62	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	108.16	1.18	0.98	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	98.14	2.13	3.47	0.56	0.45
esophagus, adult, pool1	10015-101C6	181.14	3.61	2.76	2.12	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	233.82	1.50	1.50	1.38	0.25
eye - muscle inferior rectus, donor1	10272-104E2	118.31	2.41	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	61.02	2.10	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	50.60	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	105.48	3.44	2.29	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	65.58	4.37	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	166.52	5.59	3.56	1.53	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	76.42	3.85	5.00	0.26	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	86.66	4.51	4.04	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	656.39	42.03	34.25	15.67	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	136.01	1.50	1.80	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	114.57	0.73	0.91	0.55	0.00
gall bladder, adult	10198-103E9	91.02	3.86	2.66	1.21	0.48
gamma delta positive T cells, donor1	11937-126A2	326.94	26.84	19.86	4.83	1.07
gamma delta positive T cells, donor2	11938-126A3	283.85	19.80	17.18	3.73	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	85.12	0.84	0.63	0.84	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	125.53	2.32	1.35	0.00	1.16
gastric cancer cell line:AZ521	10549-107H9	161.99	1.97	1.48	1.48	0.16
gastric cancer cell line:GSS	10560-108A2	64.98	1.83	1.83	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	155.58	4.11	2.28	0.91	0.91
giant cell carcinoma cell line:LU65	10487-107B1	52.32	0.34	1.38	1.03	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	189.50	0.14	0.84	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	80.06	0.50	1.25	0.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	213.22	2.85	3.17	1.79	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	211.50	3.51	2.95	0.84	0.56
glioblastoma cell line:T98G	10485-107A8	187.86	4.19	5.74	1.32	0.44
glioma cell line:GI-1	10413-106B8	183.05	1.76	2.93	1.46	0.29
globus pallidus - adult, donor10196	10175-103C4	511.70	14.58	16.04	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	884.35	32.95	14.65	4.39	1.95
globus pallidus, adult, donor10258	10367-105F7	629.84	39.71	8.22	2.74	5.48
globus pallidus, newborn, donor10223	10364-105F4	122.57	11.19	7.46	2.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	63.63	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	104.64	7.04	3.52	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	157.48	5.05	4.13	2.75	0.46
hIPS +CCl2, biol_rep2	14384-156C1	167.82	6.40	4.12	0.91	1.83
hIPS +CCl2, biol_rep3	14385-156C2	137.84	1.29	2.58	0.64	1.29
hIPS, biol_rep1	14380-156B6	182.54	10.06	8.62	2.87	1.44
hIPS, biol_rep2	14381-156B7	122.08	3.43	4.80	0.00	0.69
hIPS, biol_rep3	14382-156B8	328.83	17.66	19.86	7.72	3.31
hairy cell leukemia cell line:Mo	10712-109I1	54.60	1.15	0.57	0.00	2.59
heart - mitral valve, adult	10205-103F7	188.95	5.38	4.19	1.79	0.60
heart - pulmonic valve, adult	10206-103F8	170.48	5.75	4.97	2.35	0.78
heart - tricuspid valve, adult	10207-103F9	116.57	4.16	2.50	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	42.44	1.43	0.82	0.82	0.61
heart, adult, diseased, donor1	10051-101G6	31.09	1.70	1.70	0.85	0.00
heart, adult, pool1	10016-101C7	98.20	5.06	6.67	1.61	0.23
heart, fetal, pool1	10046-101G1	295.82	6.47	6.78	1.54	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	107.06	8.95	6.48	2.16	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	51.13	8.32	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	80.88	3.54	3.98	0.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	95.28	2.91	2.91	1.09	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	105.80	3.54	5.15	1.21	0.40
hepatoma cell line:Li-7	10484-107A7	97.87	0.56	0.89	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	103.52	1.91	2.31	0.20	0.20
hippocampus - adult, donor10196	10169-103B7	401.24	17.98	12.30	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	604.54	24.90	15.31	6.53	2.25
hippocampus, adult, donor10258	10374-105G5	435.21	47.80	18.92	18.42	7.47
hippocampus, newborn, donor10223	10363-105F3	111.03	10.93	6.70	4.58	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	217.28	3.66	6.71	3.66	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	91.89	1.96	3.14	0.59	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	103.59	3.55	2.03	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	73.87	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	95.02	0.77	0.52	0.52	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	103.63	0.76	0.38	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	117.66	0.00	0.00	0.00	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	104.27	0.65	0.22	0.86	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	108.86	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	195.59	2.13	0.24	0.71	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	134.36	1.77	1.13	0.32	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	191.22	1.35	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	92.64	2.82	2.66	0.16	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	115.95	1.47	3.93	0.49	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	156.22	3.49	3.49	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	100.61	0.19	0.19	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	86.34	0.44	2.18	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	136.43	1.00	1.00	1.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	80.82	0.00	0.19	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	91.85	0.00	0.91	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	73.61	0.00	0.00	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	106.15	1.31	0.49	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	112.06	0.87	0.58	0.29	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	78.62	0.60	0.90	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	109.74	2.77	1.48	0.37	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	107.55	3.14	1.43	0.57	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	165.37	3.67	4.90	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	132.03	2.11	1.76	0.70	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	91.22	0.63	0.95	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	90.18	2.12	0.61	0.30	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	90.50	0.52	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	95.64	0.66	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	105.43	0.26	0.51	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	123.73	0.51	0.51	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	102.23	0.76	1.51	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	107.87	2.02	1.68	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	100.95	0.97	1.45	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	133.70	3.12	0.89	1.34	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	102.93	1.95	1.46	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	98.71	0.31	0.92	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1265.51	0.00	3.25	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	156.87	0.00	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	106.18	0.00	0.00	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	91.56	0.36	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	107.12	0.00	1.07	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	96.66	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	208.96	1.63	0.81	0.41	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	99.95	0.54	0.27	0.27	0.27
immature langerhans cells, donor1	11904-125F5	138.27	4.12	2.42	0.73	0.48
immature langerhans cells, donor2	11905-125F6	43.57	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	249.64	26.59	19.31	6.62	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	54.62	0.65	1.30	0.33	0.33
kidney, adult, pool1	10017-101C8	148.49	2.30	2.10	1.30	0.50
kidney, fetal, pool1	10045-101F9	39.75	1.20	1.20	0.50	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	145.00	2.56	1.70	1.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	41.47	0.55	0.14	0.14	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	96.89	1.28	1.83	0.55	0.55
left atrium, adult, donor1	10079-102A7	88.81	1.63	2.18	1.09	1.09
left ventricle, adult, donor1	10078-102A6	75.85	3.03	3.03	1.01	1.52
leiomyoblastoma cell line:G-402	10721-110A1	72.51	3.01	5.75	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	43.47	1.44	1.80	0.36	1.44
leiomyoma cell line:15242A	10570-108B3	48.91	2.17	2.17	1.09	0.00
leiomyoma cell line:15425	10571-108B4	98.58	1.46	1.70	1.46	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	196.83	44.45	19.05	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	3.14	1.05	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	111.56	0.94	0.71	0.00	0.59
liposarcoma cell line:KMLS-1	10782-110G8	140.28	1.41	1.72	1.41	0.31
liposarcoma cell line:SW 872	10726-110A6	164.85	5.85	6.58	1.22	0.73
liver, adult, pool1	10018-101C9	85.73	2.43	1.78	0.97	0.32
liver, fetal, pool1	10086-102B5	21.64	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	350.71	10.50	8.90	3.06	1.60
locus coeruleus, adult, donor10252	10165-103B3	468.57	14.21	11.07	3.14	1.66
locus coeruleus, adult, donor10258	10375-105G6	198.34	8.75	3.10	1.13	3.39
locus coeruleus, newborn, donor10223	10362-105F2	277.19	9.25	4.21	2.52	0.42
lung adenocarcinoma cell line:A549	10499-107C4	56.74	0.83	0.28	0.97	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	130.30	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	65.38	0.40	0.26	0.40	0.26
lung, adult, pool1	10019-101D1	158.53	3.07	3.43	1.18	0.35
lung, fetal, donor1	10068-101I5	443.24	11.13	6.28	5.71	0.29
lung, right lower lobe, adult, donor1	10075-102A3	83.40	2.75	2.29	1.37	1.37
lymph node, adult, donor1	10077-102A5	90.41	2.37	3.31	1.89	2.37
lymphangiectasia cell line:DS-1	10727-110A7	78.25	1.75	1.10	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	250.99	1.66	2.57	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	118.08	1.70	0.00	1.70	0.00
mature adipocyte, donor1	12231-129F8	75.92	1.78	4.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	123.69	1.87	2.91	2.70	0.00
mature adipocyte, donor3	12233-129G1	118.77	1.42	1.19	1.42	0.00
mature adipocyte, donor4	12234-129G2	133.45	2.63	1.58	1.32	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	115.32	1.43	0.71	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	418.50	41.74	37.23	20.30	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	627.67	31.45	26.11	7.17	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	325.95	22.87	19.06	10.48	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	712.24	39.66	24.31	9.38	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	578.14	30.71	32.40	14.18	13.67
medial temporal gyrus, adult, donor10252	10156-103A3	669.36	34.38	21.22	6.79	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	522.02	50.08	30.82	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	6272.53	129.18	129.18	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	207.46	20.10	8.61	7.54	2.15
medulla oblongata - adult, donor10196	10174-103C3	295.28	7.79	3.89	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	399.55	11.61	7.89	3.25	1.24
medulla oblongata, adult, pool1	10038-101F2	193.54	9.31	5.22	3.27	0.16
medulla oblongata, newborn, donor10223	10361-105F1	162.13	9.72	5.21	2.78	0.69
medulloblastoma cell line:D283 Med	10838-111E1	52.92	0.66	0.22	0.66	0.89
medulloblastoma cell line:ONS-76	10759-110E3	60.16	5.01	8.80	0.98	0.12
melanoma cell line:COLO 679	10514-107E1	175.80	4.02	1.72	1.29	0.14
melanoma cell line:G-361	10465-106H6	252.19	1.90	2.44	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	53.55	0.90	0.54	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	163.90	0.88	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	110.69	2.33	0.52	1.30	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	115.54	2.76	2.30	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	95.98	2.36	2.18	0.91	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	77.44	0.83	2.07	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	132.05	2.25	3.23	1.40	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	72.60	4.24	4.43	1.54	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	84.68	2.78	2.78	0.00	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	50.46	3.78	1.72	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	71.65	3.34	2.76	1.38	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	100.14	3.32	1.86	1.46	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	106.41	3.24	4.05	0.81	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	117.79	5.12	5.55	1.28	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.79	1.32	0.66	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	110.97	3.87	2.77	1.94	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	109.96	3.14	2.44	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	85.95	6.74	2.65	2.04	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	61.83	4.31	3.24	2.88	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	96.83	2.79	2.79	2.07	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	65.89	8.89	6.16	1.60	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	210.20	6.71	11.33	3.78	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	87.12	2.09	3.14	0.90	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	98.65	3.76	2.71	1.14	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	94.62	2.21	2.95	2.95	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	78.12	4.58	6.30	0.86	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	168.83	6.74	5.47	2.11	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	65.76	1.83	3.20	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	115.61	2.81	3.58	0.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	86.90	2.62	3.14	1.83	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	80.41	2.46	2.46	1.85	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	108.03	2.12	2.82	1.88	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	103.23	3.05	1.02	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	82.92	3.14	2.36	3.14	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	99.63	3.24	3.71	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	128.63	3.17	2.02	1.73	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	98.16	3.35	1.56	1.34	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	108.40	1.68	3.12	1.92	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	140.07	1.47	1.47	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	86.60	2.35	2.01	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	84.74	2.46	2.46	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	101.81	2.58	4.73	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	0.00	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	175.61	0.00	5.16	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	95.81	2.60	2.60	1.30	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	100.39	1.45	4.36	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	84.23	3.73	2.13	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	76.87	0.00	2.45	0.82	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	78.91	1.94	1.94	1.17	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	100.74	2.10	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	86.43	3.97	0.99	0.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	4.77	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	67.60	4.74	1.78	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	87.73	2.44	3.66	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	103.24	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	68.29	2.07	1.38	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	70.92	2.15	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	63.87	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	55.42	0.41	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	49.26	1.59	0.00	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	51.29	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	57.04	0.94	0.62	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	70.84	1.34	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	67.41	2.37	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	92.45	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	82.61	2.07	2.07	0.69	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	61.85	0.99	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	50.47	2.24	1.12	0.00	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	54.70	2.54	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	26.19	2.01	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	27.88	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	37.02	2.43	0.61	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	38.71	0.82	1.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	141.08	9.92	3.97	0.99	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	103.84	7.79	1.95	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	92.70	5.09	2.04	4.07	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	131.53	10.06	3.09	3.87	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	124.26	0.24	1.65	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	225.88	13.44	6.95	5.10	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	119.66	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	141.49	5.86	2.88	1.13	1.75
mesothelioma cell line:Mero-25	10850-111F4	32.23	1.13	0.91	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	162.82	4.65	3.18	1.22	2.20
mesothelioma cell line:Mero-48a	10852-111F6	151.68	7.09	5.76	0.89	1.11
mesothelioma cell line:Mero-82	10853-111F7	141.13	2.37	3.42	1.31	2.63
mesothelioma cell line:Mero-83	10854-111F8	133.11	3.74	3.57	1.19	1.19
mesothelioma cell line:Mero-84	10855-111F9	65.47	3.29	2.53	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	150.73	10.35	5.59	3.11	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	80.67	3.48	1.33	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	241.99	10.14	8.51	2.17	3.80
mesothelioma cell line:NCI-H2452	10848-111F2	143.49	3.25	1.71	0.34	1.20
mesothelioma cell line:NCI-H28	10845-111E8	88.81	1.53	0.25	1.02	1.53
mesothelioma cell line:No36	10857-111G2	121.67	5.22	4.57	0.65	1.30
mesothelioma cell line:ONE58	10858-111G3	99.17	1.90	0.54	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	194.99	0.77	0.96	1.34	0.19
migratory langerhans cells, donor2	11902-125F3	141.53	0.98	0.98	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	211.61	0.90	1.26	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	87.82	0.65	1.96	0.33	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	39.21	1.48	2.33	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.47	0.92	0.92	1.38	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	80.30	2.09	2.09	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	231.91	1.66	2.40	0.92	0.37
myeloma cell line:PCM6	10474-106I6	118.60	0.20	0.00	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	86.75	2.54	5.07	2.03	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	128.28	2.75	2.94	1.18	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	37.55	0.56	0.78	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.32	0.51	0.96	0.37	0.00
nasal epithelial cells, donor2	12227-129F4	119.78	1.66	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	208.90	0.00	0.46	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	268.84	6.17	2.06	1.68	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	114.09	0.84	0.42	0.21	1.48
neuroblastoma cell line:NH-12	10555-107I6	194.92	0.37	0.56	0.56	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	146.13	1.66	1.90	0.71	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	67.47	1.58	2.22	1.58	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	97.21	2.62	2.82	1.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.78	3.81	3.81	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	111.79	9.05	5.59	0.80	0.53
neutrophil PMN, donor1	12133-128D9	148.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	604.94	1.69	2.03	0.00	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	150.50	3.20	1.60	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	174.73	8.66	3.85	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	135.06	14.19	7.62	2.89	1.84
nucleus accumbens, adult, pool1	10037-101F1	358.18	28.22	22.31	7.87	0.19
occipital cortex - adult, donor10196	10172-103C1	688.17	26.78	35.03	14.42	10.30
occipital cortex, adult, donor10252	10163-103B1	702.84	27.64	18.79	5.90	1.88
occipital cortex, newborn, donor10223	10355-105E4	260.58	43.31	21.84	12.01	0.36
occipital lobe, adult, donor1	10076-102A4	334.30	32.80	22.83	12.07	1.05
occipital lobe, fetal, donor1	10073-102A1	245.87	2.57	1.72	0.00	2.57
occipital pole, adult, pool1	10036-101E9	88.14	13.88	10.33	4.73	0.16
olfactory region, adult	10195-103E6	433.50	30.19	22.35	6.69	3.82
optic nerve, donor1	10277-104E7	542.28	32.02	6.00	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	104.34	0.68	0.46	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	108.81	0.41	0.69	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	97.02	1.35	2.03	0.51	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	119.55	2.08	2.08	0.58	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	81.72	1.18	1.76	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	303.66	5.61	4.67	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	75.71	5.73	3.61	1.27	0.00
ovary, adult, pool1	10020-101D2	229.82	3.67	2.80	2.01	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.58	5.87	6.23	1.65	0.55
pancreas, adult, donor1	10049-101G4	24.46	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.67	2.52	3.35	2.52	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	143.78	1.53	1.70	0.85	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	158.30	0.66	1.16	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	327.92	36.33	28.19	9.79	0.55
parietal cortex, adult, donor10258	10373-105G4	419.12	17.62	17.62	8.07	5.14
parietal lobe - adult, donor10196	10171-103B9	440.15	22.57	29.15	15.05	1.88
parietal lobe, adult, donor10252	10157-103A4	596.30	23.09	21.66	9.69	3.42
parietal lobe, adult, pool1	10034-101E7	248.06	28.73	21.77	9.87	0.44
parietal lobe, fetal, donor1	10072-101I9	303.56	6.79	0.97	0.00	3.88
parietal lobe, newborn, donor10223	10356-105E5	248.99	25.42	15.33	10.47	0.75
parotid gland, adult	10199-103F1	44.40	1.23	3.08	0.62	0.00
penis, adult	10200-103F2	150.39	1.61	3.76	3.22	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	162.69	2.79	1.12	0.56	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	69.93	0.15	1.02	1.02	0.15
pineal gland - adult, donor10196	10179-103C8	148.36	1.94	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	360.07	4.15	2.96	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	148.62	2.51	1.25	0.63	1.88
pituitary gland - adult, donor10196	10180-103C9	225.63	3.04	5.06	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	449.78	7.30	9.90	1.56	1.56
pituitary gland, adult, donor10258	10378-105G9	135.35	2.55	3.40	1.70	0.00
placenta, adult, pool1	10021-101D3	155.99	4.09	3.55	2.15	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	114.68	1.19	1.19	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	141.32	2.96	2.96	2.49	0.00
pons, adult, pool1	10033-101E6	534.82	16.96	11.88	10.33	0.60
postcentral gyrus, adult, pool1	10032-101E5	145.93	17.87	14.65	6.54	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	8.37	6.27	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	160.23	0.58	0.87	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	158.09	6.35	9.62	2.36	1.27
prostate, adult, pool1	10022-101D4	182.38	2.63	3.17	1.45	0.82
putamen, adult, donor10196	10176-103C5	402.96	17.94	31.16	9.91	2.60
putamen, adult, donor10252	10152-102I8	488.22	19.61	19.61	11.76	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	253.53	28.41	7.65	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	233.88	22.23	13.05	11.11	4.35
putamen, newborn, donor10223	10365-105F5	616.22	33.73	8.25	8.25	3.75
rectal cancer cell line:TT1TKB	10469-106I1	77.39	0.87	1.75	0.87	0.00
rectum, fetal, donor1	10067-101I4	187.78	5.56	4.17	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	80.35	7.63	11.02	5.51	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	169.83	0.41	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	84.39	3.28	2.88	1.69	0.30
retinoblastoma cell line:Y79	10475-106I7	136.14	0.26	0.78	0.78	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	71.19	1.48	2.46	1.48	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	548.34	16.03	14.90	2.25	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	123.53	12.88	3.79	3.03	0.00
salivary acinar cells, donor1	11771-123I7	63.77	0.16	0.32	0.16	0.00
salivary acinar cells, donor2	11772-123I8	59.34	0.83	0.96	0.83	0.28
salivary acinar cells, donor3	11773-123I9	39.06	0.66	3.97	0.00	0.00
salivary gland, adult, pool1	10093-102C3	33.17	0.57	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	199.57	0.59	0.67	0.93	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	193.49	0.47	1.06	0.71	0.24
seminal vesicle, adult	10201-103F3	79.36	2.12	2.65	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	90.37	2.19	1.70	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	44.54	2.26	1.51	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	102.36	6.02	4.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	144.39	1.21	1.34	0.54	1.34
signet ring carcinoma cell line:Kato III	10436-106E4	57.58	0.66	0.66	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	134.96	1.55	1.81	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	58.17	1.42	3.55	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	109.74	2.28	2.16	1.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	68.34	1.01	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	74.64	6.79	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	157.18	1.89	1.89	2.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	93.39	3.00	2.67	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	261.94	1.58	1.58	0.95	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	179.06	1.73	4.05	1.16	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	150.49	1.48	1.15	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	112.43	1.77	2.41	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	151.02	0.87	1.53	0.44	0.87
small intestine, adult, pool1	10024-101D6	166.98	2.51	1.91	1.19	0.24
small intestine, fetal, donor1	10064-101I1	118.18	1.72	2.21	1.47	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	116.94	0.51	0.51	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	192.55	1.29	3.10	2.84	1.55
somatostatinoma cell line:QGP-1	10781-110G7	82.28	0.54	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	413.16	10.55	7.57	3.21	4.13
spinal cord, adult, donor10252	10159-103A6	518.86	13.01	7.10	3.94	1.58
spinal cord, adult, donor10258	10369-105F9	563.12	11.07	8.30	2.08	3.46
spinal cord, fetal, donor1	10056-101H2	229.30	7.93	3.66	1.22	2.44
spinal cord, newborn, donor10223	10359-105E8	523.50	33.98	4.59	5.51	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	87.22	2.69	3.58	1.94	0.15
spleen, adult, pool1	10025-101D7	180.62	3.41	3.96	1.10	0.22
spleen, fetal, pool1	10044-101F8	52.68	1.91	2.22	1.03	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	104.86	1.66	1.04	0.41	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	93.99	0.19	1.14	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	91.91	0.70	1.40	1.05	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	60.99	3.13	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	137.43	1.01	1.24	0.68	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	113.10	3.39	4.66	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	192.50	7.62	2.96	2.96	0.42
stomach, fetal, donor1	10062-101H8	80.10	3.20	6.41	1.07	0.00
submaxillary gland, adult	10202-103F4	72.35	1.14	1.14	1.14	2.28
substantia nigra - adult, donor10196	10178-103C7	3690.64	0.00	54.27	0.00	108.55
substantia nigra, adult, donor10252	10158-103A5	632.26	17.86	10.39	2.91	2.28
substantia nigra, adult, donor10258	10371-105G2	402.94	15.52	13.45	4.66	3.10
substantia nigra, newborn, donor10223	10358-105E7	221.16	33.92	11.31	4.24	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	252.42	2.06	1.60	0.69	0.46
temporal lobe, adult, pool1	10031-101E4	111.05	15.34	12.89	4.66	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	188.75	2.14	0.00	2.85	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	195.15	0.44	1.76	0.88	0.88
tenocyte, donor1	11763-123H8	132.66	4.89	4.19	2.09	1.75
tenocyte, donor2	11765-123I1	76.30	2.29	3.05	2.29	1.14
tenocyte, donor3	11768-123I4	128.62	5.93	2.97	2.59	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	179.48	8.84	7.65	1.87	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	119.31	0.92	1.08	0.62	0.62
teratocarcinoma cell line:PA-1	10807-111A6	145.83	2.94	1.55	1.39	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	49.38	2.16	1.90	1.90	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	136.90	0.38	0.76	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	145.71	3.82	2.29	2.07	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	102.27	3.91	4.23	0.98	0.33
testis, adult, pool1	10026-101D8	143.88	4.51	6.12	3.44	0.43
testis, adult, pool2	10096-102C6	62.25	7.22	6.77	1.35	1.35
thalamus - adult, donor10196	10168-103B6	702.13	22.08	11.04	8.83	3.31
thalamus, adult, donor10252	10154-103A1	891.59	34.85	14.53	4.84	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	654.34	47.73	23.09	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	173.58	7.25	4.28	1.65	1.65
thalamus, newborn, donor10223	10366-105F6	198.49	8.05	5.18	10.93	0.00
throat, adult	10209-103G2	111.60	2.75	2.25	2.00	1.00
throat, fetal, donor1	10061-101H7	131.94	4.27	1.52	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	96.58	2.19	1.99	1.39	0.20
thymus, adult, pool1	10027-101D9	245.16	5.87	5.77	1.99	0.40
thymus, fetal, pool1	10043-101F7	278.36	5.71	5.30	1.66	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	88.15	2.26	1.99	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	72.36	2.51	2.79	1.54	0.98
thyroid, adult, pool1	10028-101E1	161.06	1.31	1.87	1.03	0.37
thyroid, fetal, donor1	10060-101H6	95.18	2.64	2.11	0.79	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	3.08	0.00	9.24	0.00
tongue, adult	10203-103F5	103.96	3.26	2.09	1.63	1.63
tongue, fetal, donor1	10059-101H5	137.54	4.34	0.79	3.15	1.18
tonsil, adult, pool1	10047-101G2	73.03	2.50	2.80	1.20	0.00
trachea, adult, pool1	10029-101E2	138.98	2.54	3.27	1.88	0.00
trachea, fetal, donor1	10058-101H4	122.72	3.08	2.31	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	89.99	3.54	3.19	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	220.36	2.13	1.62	0.91	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	87.27	1.10	0.94	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	83.71	0.00	9.51	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	65.27	0.51	0.85	0.17	0.51
umbilical cord, fetal, donor1	10057-101H3	104.33	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	152.54	4.27	2.22	2.05	0.17
uterus, fetal, donor1	10055-101H1	246.24	3.58	3.58	3.07	1.54
vagina, adult	10204-103F6	120.19	1.94	0.65	1.29	0.65
vein, adult	10191-103E2	74.53	3.07	2.63	2.41	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	85.18	0.53	1.60	0.53	0.27